Collectively, these findings provide the rationale and foundation for the innovative adaptive design of AdvanCell’s ongoing Phase 1b/2 TheraPb trial of ADVC001 (NCT05720130), the Company’s ...
Apple’s iPhone 17 line-up makes its boldest shift since iPhone X: 3,000-nit displays, longer battery life, steadier A19 Pro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback